Diabetic Retinopathy Market Size, Share & Trends Report

Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative Diabetic Retinopathy), By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Region And Segment Forecasts, 2025 - 2030

Report ID: 978-1-68038-466-6
Number of Report Pages: 100
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Type Outlook (Revenue in USD Million, 2018 - 2030)
- Proliferative Diabetic Retinopathy
- Non-proliferative Diabetic Retinopathy
Management Outlook (Revenue in USD Million, 2018 - 2030)
- Anti-VEGF
- Intraocular Steroid Injection
- Laser Surgery
- Vitrectomy
Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Proliferative Diabetic Retinopathy
    - Non-proliferative Diabetic Retinopathy
  - North America Management Outlook (Revenue in USD Million, 2018 - 2030)
    - Anti-VEGF
    - Intraocular Steroid Injection
    - Laser Surgery
    - Vitrectomy
  - U.S.
    - U.S. Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - U.S. Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Canada
    - Canada Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Canada Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Mexico
    - Mexico Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Mexico Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
- Europe
  - Europe Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Proliferative Diabetic Retinopathy
    - Non-proliferative Diabetic Retinopathy
  - Europe Management Outlook (Revenue in USD Million, 2018 - 2030)
    - Anti-VEGF
    - Intraocular Steroid Injection
    - Laser Surgery
    - Vitrectomy
  - Germany
    - Germany Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Germany Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - UK
    - UK Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - UK Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - France
    - France Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - France Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Italy
    - Italy Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Italy Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Spain
    - Spain Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Spain Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Denmark
    - Denmark Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Denmark Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Sweden
    - Sweden Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Sweden Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Norway
    - Norway Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Norway Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
- Asia Pacific
  - Asia Pacific Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Proliferative Diabetic Retinopathy
    - Non-proliferative Diabetic Retinopathy
  - Asia Pacific Management Outlook (Revenue in USD Million, 2018 - 2030)
    - Anti-VEGF
    - Intraocular Steroid Injection
    - Laser Surgery
    - Vitrectomy
  - China
    - China Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - China Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Japan
    - Japan Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Japan Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - India
    - India Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - India Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Thailand
    - Thailand Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Thailand Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - South Korea
    - South Korea Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - South Korea Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Australia
    - Australia Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Australia Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
- Latin America
  - Latin America Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Proliferative Diabetic Retinopathy
    - Non-proliferative Diabetic Retinopathy
  - Latin America Management Outlook (Revenue in USD Million, 2018 - 2030)
    - Anti-VEGF
    - Intraocular Steroid Injection
    - Laser Surgery
    - Vitrectomy
  - Brazil
    - Brazil Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Brazil Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Argentina
    - Argentina Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Argentina Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
- Middle East and Africa
  - Middle East and Africa Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Proliferative Diabetic Retinopathy
    - Non-proliferative Diabetic Retinopathy
  - Middle East and Africa Management Outlook (Revenue in USD Million, 2018 - 2030)
    - Anti-VEGF
    - Intraocular Steroid Injection
    - Laser Surgery
    - Vitrectomy
  - South Africa
    - South Africa Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - South Africa Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Saudi Arabia
    - Saudi Arabia Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Saudi Arabia Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - UAE
    - UAE Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - UAE Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy
  - Kuwait
    - Kuwait Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Proliferative Diabetic Retinopathy
      - Non-proliferative Diabetic Retinopathy
    - Kuwait Management Outlook (Revenue in USD Million, 2018 - 2030)
      - Anti-VEGF
      - Intraocular Steroid Injection
      - Laser Surgery
      - Vitrectomy

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.